Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      KemPharms opioid painkiller gets FDA approval

      KemPharm's opioid painkiller gets FDA approval

      Ruby Khatun Khatun27 Feb 2018 9:30 AM IST
      KemPharm Inc said the U.S. Food and Drug Administration approved its opioid painkiller Apadaz for the short-term management of acute pain.The company...
      Big Boost to Medical Equipment Sector: AP signs MOUs worth Rs 8000 crore

      Big Boost to Medical Equipment Sector: AP signs MOUs worth Rs 8000 crore

      Ruby Khatun Khatun26 Feb 2018 5:17 PM IST
      Visakhapatnam: Andhra Pradesh will soon get a big push in the medical equipment and devices sector as the state government has signed 25 MoUs with...
      Dr Reddys gets EIR from USFDA for Srikakulam plant

      Dr Reddy's gets EIR from USFDA for Srikakulam plant

      Ruby Khatun Khatun26 Feb 2018 11:52 AM IST
      New Delhi: Pharma major Dr Reddy's Laboratories (DRL) said it has received the establishment inspection report (EIR) from the US Food and Drug...
      20 ayurvedic healthcare centres set up in 3 NE states

      20 ayurvedic healthcare centres set up in 3 NE states

      Ruby Khatun Khatun26 Feb 2018 10:30 AM IST
      Guwahati: At least 20 ayurvedic healthcare centres have recently been set up in Assam, Sikkim and Arunachal Pradesh, Union Minister Sripad Naik...
      India, Uzbek region ink pharma pact

      India, Uzbek region ink pharma pact

      Ruby Khatun Khatun26 Feb 2018 10:15 AM IST
      New Delhi: The Andijan Region of Uzbekistan and India have inked an agreement for cooperation in the pharmaceutical industry.A joint statement...
      Merck to buy Viralytics for 394 million dollars

      Merck to buy Viralytics for 394 million dollars

      Ruby Khatun Khatun26 Feb 2018 10:00 AM IST
      U.S. drugmaker Merck & Co, already one of the leaders in the hot area of cancer immunotherapy, said it had agreed to buy Viralytics for 502...
      Daiichi Sankyo initiates phase 1 study of DS-1062 in patients with advanced NSCLC

      Daiichi Sankyo initiates phase 1 study of DS-1062 in patients with advanced NSCLC

      Ruby Khatun Khatun26 Feb 2018 9:45 AM IST
      TOKYO, BASKING RIDGE, N.J. and MUNICH: Daiichi Sankyo announced the first patient has been dosed in a phase 1 study assessing the safety and...
      EU panel recommends against nod for Puma Biotechs breast cancer drug

      EU panel recommends against nod for Puma Biotech's breast cancer drug

      Ruby Khatun Khatun26 Feb 2018 9:30 AM IST
      A European Medicines Agency (EMA) panel recommended against approving Puma Biotechnology’s lead breast cancer drug, an outcome the U.S drugmaker had...
      Biocon to set up research and development unit in Telangana

      Biocon to set up research and development unit in Telangana

      Ruby Khatun Khatun25 Feb 2018 12:30 PM IST
      Hyderabad: Biopharmaceuticals firm Biocon will soon start a research and development (R&D) lab of its subsidiary Syngene in Genome Valley in...
      Lupin launches dementia drug in US

      Lupin launches dementia drug in US

      Ruby Khatun Khatun25 Feb 2018 11:00 AM IST
      New Delhi: Drug firm Lupin said it has launched its Memantine Hydrochloride extended-release capsules in the American market after getting approval...
      Jubilant Life Sciences promoters sell stake worth Rs 455 crore

      Jubilant Life Sciences promoters sell stake worth Rs 455 crore

      Ruby Khatun Khatun25 Feb 2018 10:30 AM IST
      New Delhi: Two promoters of drug firm Jubilant Life Sciences sold 3 percent stake in the company for over Rs 455 crore, through open market...
      Anti-dumping duty likely on chemical imported from China, Turkey

      Anti-dumping duty likely on chemical imported from China, Turkey

      Ruby Khatun Khatun25 Feb 2018 10:15 AM IST
      New Delhi: The government is likely to impose anti-dumping duty of up to USD 211 per tonne on a chemical used in textiles and pharma industry,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok